Cancer incidence in the multicenter aids cohort study before and during the HAART era
Open Access
- 29 November 2010
- Vol. 116 (23) , 5507-5516
- https://doi.org/10.1002/cncr.25530
Abstract
BACKGROUND: The incidence of Kaposi sarcoma (KS) and non‐Hodgkin lymphoma (NHL) among human immunodeficiency virus (HIV)‐infected individuals declined after the introduction of highly active antiretroviral therapy (HAART) in the mid‐1990s, but the cancer risk associated with HIV infection during the HAART era remains to be clarified. METHODS: Cancer incidence among HIV‐infected and HIV‐uninfected participants in the Multicenter AIDS (acquired immunodeficiency syndrome) Cohort Study (MACS) between 1984 and 2007 was compared with the expected incidence using US population‐based data from the Surveillance, Epidemiology, and End Results (SEER) program. Age‐ and race‐adjusted cancer incidence rates were also compared HIV by status and over time within the MACS. Exact statistical methods were used for all analyses. RESULTS: A total of 933 incident cancers were observed during 77,320 person‐years of follow‐up. Compared with SEER, MACS HIV‐infected men had significantly (P < .05) elevated rates of KS (standardized incidence ratio [SIR], 139.10), NHL (SIR, 36.80), Hodgkin lymphoma (HL)(SIR, 7.30), and anal cancer (SIR, 25.71). Within MACS, HIV infection was found to be independently associated with each of these cancers across the entire follow‐up period, and KS (incidence rate ratio [IRR], 54.93), NHL (IRR, 11.18), and anal cancer (IRR, 18.50) were each found to be significantly elevated among HIV‐infected men during the HAART era. Among these men, the incidence of KS and NHL declined (IRR, 0.13 and 0.23, respectively), the incidence of anal cancer increased (IRR, 5.84), and the incidence of HL remained statistically unchanged (IRR, 0.75) from the pre‐HAART to the HAART era. CONCLUSIONS: Cancer risk remains elevated among HIV‐infected men who have sex with men, highlighting the continuing need for appropriate cancer screening in this population. Cancer 2010. © 2010 American Cancer Society.Keywords
This publication has 34 references indexed in Scilit:
- Highly Active Antiretroviral Therapy and the Incidence of Non–AIDS-Defining Cancers in People With HIV InfectionJournal of Clinical Oncology, 2009
- Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort studyAIDS, 2009
- Living longer with HIV: what does it mean for cancer risk?Current Opinion in HIV and AIDS, 2009
- Incidence and Epidemiology of Anal Cancer in the Multicenter AIDS Cohort StudyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2008
- Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studiesThe Lancet, 2008
- Underestimation of Relative Risks by Standardized Incidence Ratios for AIDS-Related CancersAnnals of Epidemiology, 2008
- Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individualsAIDS, 2008
- AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy eraCurrent Opinion in Oncology, 2007
- HIV Infection Is Associated with an Increased Risk for Lung Cancer, Independent of SmokingClinical Infectious Diseases, 2007
- The Clinical Effectiveness and Cost-effectiveness of Screening for Anal Squamous Intraepithelial Lesions in Homosexual and Bisexual HIV-Positive MenJAMA, 1999